Cervical Cancer Clinical Trials in Fuzhou, Fujian
9 recruitingFuzhou, Fujian, China
Showing 1–9 of 9 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC686 enrolled239 locationsNCT06459180
Recruiting
Phase 1Phase 2
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Colorectal, CancerCervical CancerLung Cancer+4 more
Sichuan Enray Pharmaceutical Sciences Company54 enrolled9 locationsNCT07433283
Recruiting
Phase 2
A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer
Recurrent or Metastatic Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd.60 enrolled2 locationsNCT07051486
Recruiting
Phase 2
Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)
Locally Advanced Cervical Cancer
Fujian Cancer Hospital43 enrolled1 locationNCT07055399
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects with Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.200 enrolled24 locationsNCT06799637
Recruiting
Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer
Cervical Cancer
Fujian Cancer Hospital200 enrolled1 locationNCT06140589
Recruiting
Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors
Cervical CancerNeuroendocrine NeoplasmWomen+2 more
Fujian Maternity and Child Health Hospital300 enrolled9 locationsNCT06276309
Recruiting
Phase 2
Nituzumab Plus Serplulimab Combined With SBRT in Cervical Cancer
Cervical Cancer
Fujian Cancer Hospital37 enrolled1 locationNCT06455072
Recruiting
Phase 2
Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
Cervical Cancer Recurrent
Fujian Cancer Hospital37 enrolled1 locationNCT06455046